Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Nanoviricides Inc (NNVC)

0.53 -0.018 (-3.27%)

05-21 15:58

Open:

0.55

Pre. Close:

0.5479

High:

0.5798

Low:

0.505

Volume:

247,638

Market Cap:

34M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.581 - 0.584

0.584 - 0.588

Low:

0.492 - 0.495

0.495 - 0.499

Close:

0.524 - 0.529

0.529 - 0.536

Technical analysis  (as of: 2018-05-21 4:31:55 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 0.83     One year: 0.99

Support:

Support1: 0.48    Support2: 0.40

Resistance:

Resistance1: 0.71    Resistance2: 0.85

Pivot:

0.62

Moving Averages:

MA(5): 0.53     MA(20): 0.65

MA(100): 0.85     MA(250): 1.07

MACD:

MACD(12,26): -0.07     Signal(12,26,9): -0.06

%K %D:

%K(14,3): 23.05     %D(3): 18.74

RSI:

RSI(14): 28.53

52-Week:

High: 1.64  Low: 0.48  Change(%): -59.8

Average Vol(K):

3-Month: 12534  10-Days 20325

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
NNVC has closed above bottom band by 22.1%. Bollinger Bands are 106.4% wider than normal. The large width of the bands suggest high volatility as compared to NNVC's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

2018-04-09T07:00:00-04:00
NanoViricides Reports Good Safety Profile of Topical Dermal Drug Candidates; Dr. Diwan, President, Will Present at the MicroCap Conference in New York City Today

2018-03-19T11:12:00-04:00
NanoViricides Drug Candidates to be Tested in Animal Models of Dermal, Ocular and Genital Herpes Virus Infection at the University of Wisconsin

2018-02-21T07:00:00-05:00
NanoViricides Files Quarterly Report for Period Ending December 31, 2017

2018-02-14T09:00:00-05:00
ChickenSoup Entertainment Is A Toxic Mess

2017-12-06T07:00:00-05:00
Nanoviricides Initiates a Safety/Toxicology Study of Its Leading Shingles Candidates

2017-11-20T10:51:54-05:00
Your Daily Pharma Scoop: Geron's Fate, Celldex Commences Mid-Stage Study, Novartis's Tasigna

2017-11-20T07:00:00-05:00
NanoViricides Files Quarterly Report for Period Ending September 30, 2017

2017-11-06T07:00:00-05:00
NanoViricides Provides Further Details on Its Herpes-Induced Acute Retinal Necrosis Animal Study to be Presented On November 10th at the Annual Meeting of the Ocular Microbiology and Immunology Group (OMIG) of the American Academy of Ophthalmology

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

63.37

Shares Float (M)

58.73

% Held by Insiders

7.30

% Held by Institutions

5.10

Shares Short (K)

239

Shares Short Prior Month (K)

1480

Stock Financials

EPS

EPS Est. Current Year

-0.200

EPS Est. Next Year

0.040

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

2.540

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-38.1

Return on Equity (ttm)

-59.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-6.02

Levered Free Cash Flow (M)

-2.81

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

0.21

P/S

P/CF

-5.58

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-09-10

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.